Recent advancements in HIV treatment and prevention, including the roll-out of pre-exposure prophylaxis (PrEP) and the bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) treatment regimen, have highlighted the critical need for ethnic-centered approaches in healthcare.Therefore, understanding
Watson & Company's mental wellness electroceutical tool, Pocus, is receiving attention from industry watchers and the public after showcasing its potential at the 2022 Hangzhou Asian Games, where athletes used it to manage stress and improve sleep quality.Pocus is a wearable device that applies neur
Curocell, a local chimeric antigen receptor-T (CAR-T) developer, said it will start developing a next-generation Anti-CD19 CAR-T therapy for treatment-resistant systemic lupus erythematosus (SLE) as part of the2024 Multi-Ministerial Regenerative Medicine Technology Development Program.This initiativ
Daewoong Pharmaceutical said that it applied for product approval for Envlo, the first homegrown sodium-glucose cotransporter 2 (SGLT2) diabetes drug in Korea and the nation's 36th newly developed drug, to Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).COFEPRIS is
The Korea Exchange (KRX) has suspended stock trading of EONE-Diagnomics Genome Center (EDGC), a Kosdaq-listed genomic analysis company, due to unverified rumors that the company received a disclaimer of opinion during its audit process.The suspension took effect when the market opened Monday, with K
Seegene, a Korean in vitro diagnostics company, recently hosted Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), at its headquarters in Songpa-gu, Seoul.The visit, which took place on March 27, served as a platform for both parties to discuss innovative strategies to create a
Lunit said it published a study showing that using Lunit Insight MMG, its AI image analysis solution for mammography, can increase the likelihood of early breast cancer diagnosis and significantly reduce the workload of physicians.The study, conducted in collaboration with researchers from various u
EuBiologics, a Korean vaccine maker targeting the global public health market, said it opened a new office at the Cambridge Innovation Center (CIC) in Boston, one of the largest biotech clusters in the world.EuBiologics' new office opening comes after their selection by KHIDI (Korea Health Industry
A team at Severance Hospital found that stereotactic ablative radiotherapy (SABR) was effective in treating patients with limited metastatic liver cancer.Limited metastatic cancer is defined by the early stage of cancer spread, where metastasis is confined to five or fewer organs.This condition nece
In a move signaling a potential resolution to ongoing family disputes, Hanmi Science, the holding company of Hanmi Pharm, announced the appointment of Lim Jong-hoon as co-CEO alongside the current chairperson, Song Young-sook.The decision came during a board meeting held at Hanmi headquarters in Son
Celltrion has embarked on a partnership with the Crohn's & Colitis Foundation (CCF), the largest patient advocacy group for inflammatory bowel disease (IBD) in the U.S., aiming to boost awareness and improve perceptions of IBD, a chronic inflammatory condition of the gastrointestinal tract.The CCF,
Samsung Bioepis said it has commenced global phase 3 clinical trials for its biosimilar, SB27, a biosimilar referencing Keytruda, a blockbuster cancer treatment developed by MSD.SB27 marks the company's eleventh biosimilar pipeline, illustrating its ongoing commitment to expanding its portfolio in t
The Fair Trade Commission (FTC) is reportedly looking into Novo Nordisk Korea over allegations of monopolistic practices related to the cessation of its needle supply, NovoFine Plus pen needle.On Thursday, Joongang Ilbo, a Korean daily newspaper, first reported that the FTC's Seoul office dispatched
The Ministry of Health and Welfare, in collaboration with the Korea Health Industry Development Institute and Novo Nordisk, hosted the "Novo Nordisk Partnering Day- Korea 2024" on Thursday.The two-day event, part of a broader open innovation initiative, aims to foster collaboration between startups
Seoul National University Bundang Hospital (SNUBH) said it has embarked on a mentorship to reform Colombia’s healthcare system comprehensively and strengthen its role as a future medical cooperation partner.The announcement follows the hospital staff recently visiting Colombia after the Colombia’s M
In a moving display of unity and dedication, the Korea Blood Disease & Cancer Association (KBDCA) and the Korean Multiple Myeloma Working Party (KMMWP), under the Korean Society of Hematology, concluded a ceremony to celebrate the 9th World Myeloma Awareness Month.KBDCA is a non-profit organization
In a troubling trend for the biotechnology sector in Korea, several companies are on the brink of delisting from the tech-heavy Kosdaq due to failing to secure necessary audit approvals amidst a harsh investment climate and lackluster sales and research outcomes.According to reports from the Korea E
Vivozon Group, comprising Vivozon and Vivozon Pharmaceutical, has joined forces with Boryung to commercialize Vivozon's domestically developed non-narcotic painkiller, opiranserin (VVZ-149), in Korea.The partnership was formalized through a memorandum of understanding (MOU) signed on Wednesday, whic
Samsung Bioepis said it domestically released Epysqli (ingredient: eculizumab), a biosimilar referencing Soliris, at a much lower price than the original, on Monday. Soliris, developed by Alexion Pharmaceuticals and marketed by AstraZeneca, is used for treating rare conditions such as paroxysmal noc
AITRICS and Korea University Anam Hospital (KUAH) have signed a memorandum of understanding to advance medical AI technology.AITRICS is renowned for its expertise in biometric signal-based medical AI technology. Its flagship AI solution, AITRICS-VC, is designed to predict deteriorations in patient c